End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19
Richard Pebody(National Security Agency), Maria Zambon(Public Health England), Jillian Johnston, Simon de Lusignan(University of Oxford), Jim McMenamin(Public Health Scotland), Diogo Marques(Public Health Scotland), Rory Gunson(NHS Greater Glasgow and Clyde), Chris Robertson(University of Strathclyde), Samantha J. Shepherd, Katie Owens(Public Health England), Catherine Moore(University of Oxford), Mónica Galiano(Public Health England), Catherine Thompson(Public Health England), Mark G. O’Doherty(Public Health Agency), Angie Lackenby(Public Health England), Nick Andrews(Environment Agency), Matthew Donati(Public Health England), Joanna Ellis(Public Health England), Simon Cottrell(Public Health Wales), Ivelina Yonova(University of Surrey), Arlene Reynolds(Health Protection Scotland), Heather Whitaker(Public Health Agency of Canada)
Cited by 59
Related Papers
Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group
|Journal of Virology|2013|1.3k
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
|The Lancet|2003|1.1k
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
|Nature Microbiology|2022|724